PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) announced today that five posters on selected studies assessing the anti-infective nature of Microcyn® Technology were accepted for presentation at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) at McCormick Place in Chicago, September 17 - 20. ICAAC, a key scientific event, attracts scientists from around the world to discuss important themes and present the newest treatment advances in infectious disease. Oculus Innovative Sciences will also have a presence with a scientific exhibit at booth #554 located in the exhibit hall at McCormick Place/Lakeside Center. The Oculus booth will provide additional information to prospective investigators for its upcoming Phase III trials.
